Ersell Richardson - Concepedia

Concepedia

Author

Ersell Richardson

National Cancer Institute

Also Known As

E Richardson, E. H. Richardson, E. Richardson, E. S. Richardson, Erik Richardson, Ersell Richardson, Ersell S. Richardson

18

Publications

1.7K

Citations

10

H-Index

22

Concepts

All Affiliations

National Cancer Institute BioScience Laboratories (United States)Advanced Bioscience Laboratories (United States)Data Management Services (United States)

ER

About

Ersell Richardson is an author at National Cancer Institute specializing in immunology, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.4K
2	Immunology	7	7	1.4K
3	Cell Biology	1	1	10
4	Pathology	1	1	1.2K
5	Autoimmunity	1	1	1.2K

Ersell Richardson

×

10

Publications

1.7K

Citations

10

H-Index

	Year	Citations
Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS) Robert C. Gallo, Prem S. Sarin, E P Gelmann, Science Primary ImmunodeficiencyHuman RetrovirusAdult T-cell LeukemiaImmunologyHuman Type-c Retrovirus	1983	1.2K
An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge Suzan L. Buge, Ersell Richardson, Shabnam Alipanah, Journal of Virology	1997	128
Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus Marjorie Robert-Guroff, Harvinder Kaur, L. Jean Patterson, Journal of Virology	1998	63
Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) <i>env/rev</i> , <i>gag</i> , and/or <i>nef</i> Vaccines and Boosted with SIV gp120 L. Jean Patterson, Nina Malkevitch, Joel Pinczewski, Journal of Virology ImmunodeficienciesImmunologyImmunodominanceCd4 T Cell ResponsesImmune Recognition	2003	62
Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251 Suzan L. Buge, Lalita Murty, Kamalpreet Arora, Journal of Virology	1999	53
Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251 Qifeng Zhou, Rachmat Hidajat, Bo Peng, Vaccine Vaccination-Simian Immunodeficiency VirusViral ReplicationVaccine DevelopmentReplication-competent Adenovirus 5	2007	48
A Replication Competent Adenovirus 5 Host Range Mutant-Simian Immunodeficiency Virus (SIV) Recombinant Priming/Subunit Protein Boosting Vaccine Regimen Induces Broad, Persistent SIV-Specific Cellular Immunity to Dominant and Subdominant Epitopes in Mamu-A*01 Rhesus Macaques Nina Malkevitch, L. Jean Patterson, Kristine Aldrich, The Journal of Immunology Adaptive Immune SystemImmunologyViral PathogenesisP54m EpitopesCd4 T Cell Responses	2003	47
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A⁎01 negative rhesus macaques L. Jean Patterson, Jennifer Beal, Thorsten Demberg, Virology Molecular VirologyShiv89.6p ChallengeHuman RetrovirusViral PathogenesisImmunology	2008	28
A Conformational C4 Peptide Polymer Vaccine Coupled with Live Recombinant Vector Priming Is Immunogenic But Does Not Protect against Rectal SIV Challenge L. Jean Patterson, Frank A. Robey, Andrew Muck, AIDS Research and Human Retroviruses ImmunologyImmunodominanceCd4 T Cell ResponsesRectal Siv ChallengeViral Structural Protein	2001	20
Insertion of HIV-1 Genes into Ad4ΔE3 Vector Abrogates Increased Pathogenesis in Cotton Rats Due to E3 Deletion L. Jean Patterson, Gregory A. Prince, Ersell Richardson, Virology MedicineGeneticsPathogenesisImmunologyHuman Retrovirus	2002	10

Page 1